Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Bevacizumab Injection Base Year 8/13/2025 - 8/12/2026

36E79725R0019

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Pfizer Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of February 20, 2025.

N/A

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Pfizer Inc.
UEI
MHBQULRMEEJ5
CAGE
86491
Vendor location
New York, NY
Contract
36E79725D0030
Obligated
$0.00, potential $46,893,140
Actions
5 between April 11, 2025 and August 27, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Bevacizumab Injections with Pfizer, INC. Ordering Period Is August 13, 2025 to August 12, 2026 with Four ONE-YEAR Options
Match
award number 36E79725D0030 equals the contract number; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 28, 2025

    Presolicitation

    Bevacizumab Injection

    Due March 4, 2025 at 3:30 PM EST. SAM.gov, notice e10445b3a18a4fcab57f519ce36489be

  2. February 20, 2025

    Solicitation, originally presolicitation

    Bevacizumab Injection

    Due March 6, 2025 at 3:30 PM EST. SAM.gov, notice db8bdca840154d55bfed9f0551fa140c

  3. April 11, 2025

    Award notice, originally solicitation

    Awarded to Pfizer Inc. New York 10001 for $46,893,140. SAM.gov, notice 9d97dcf083c54b1c93350bdf170ca490

Points of contact

Also open from this buyer